Also known as آسٹیوپوروسس مینجمنٹ
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship Endocrinology and Diabetes
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP (UK), Fellow Rheumatology
Internal Medicine Specialist
MBBS, Internal Medicine, DABIM, M.D
Internal Medicine Specialist
M.B.B.S, M.D (USA), F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS (KEMU), FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S. , F.C.P.S. (Medicine)
Diabetologist
M.B.B.S, M.R.C.P (Ireland), M.R.C.P (Endocrinology and Diabetes - UK)
Diabetologist
M.B.B.S, M.R.C.P (Ireland), M.R.C.P (Endocrinology and Diabetes - UK)
Internal Medicine Specialist
MBBS, MRCP (London), MRCP (UK), FCPS (Pak)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures